IMTX
Price
$10.34
Change
-$0.03 (-0.29%)
Updated
Dec 26, 04:39 PM (EDT)
Capitalization
1.39B
89 days until earnings call
Intraday BUY SELL Signals
OTLC
Price
$0.09
Change
-$0.00 (-0.00%)
Updated
Dec 24 closing price
Capitalization
38.49M
Intraday BUY SELL Signals
Interact to see
Advertisement

IMTX vs OTLC

Header iconIMTX vs OTLC Comparison
Open Charts IMTX vs OTLCBanner chart's image
Immatics
Price$10.34
Change-$0.03 (-0.29%)
Volume$100
Capitalization1.39B
Oncotelic Therapeutics
Price$0.09
Change-$0.00 (-0.00%)
Volume$36.25K
Capitalization38.49M
IMTX vs OTLC Comparison Chart in %
IMTX
Daily Signal:
Gain/Loss:
OTLC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMTX vs. OTLC commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a Buy and OTLC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (IMTX: $10.37 vs. OTLC: $0.09)
Brand notoriety: IMTX and OTLC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 25% vs. OTLC: 18%
Market capitalization -- IMTX: $1.39B vs. OTLC: $38.49M
IMTX [@Biotechnology] is valued at $1.39B. OTLC’s [@Biotechnology] market capitalization is $38.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whileOTLC’s FA Score has 0 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • OTLC’s FA Score: 0 green, 5 red.
According to our system of comparison, OTLC is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 4 TA indicator(s) are bullish while OTLC’s TA Score has 3 bullish TA indicator(s).

  • IMTX’s TA Score: 4 bullish, 5 bearish.
  • OTLC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IMTX is a better buy in the short-term than OTLC.

Price Growth

IMTX (@Biotechnology) experienced а +4.54% price change this week, while OTLC (@Biotechnology) price change was -5.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

IMTX is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMTX($1.39B) has a higher market cap than OTLC($38.5M). OTLC YTD gains are higher at: 148.457 vs. IMTX (45.851). OTLC has higher annual earnings (EBITDA): -1.08M vs. IMTX (-106.34M). IMTX has more cash in the bank: 431M vs. OTLC (409K). OTLC has less debt than IMTX: OTLC (13.9M) vs IMTX (16.4M). IMTX has higher revenues than OTLC: IMTX (84.8M) vs OTLC (0).
IMTXOTLCIMTX / OTLC
Capitalization1.39B38.5M3,610%
EBITDA-106.34M-1.08M9,865%
Gain YTD45.851148.45731%
P/E Ratio27.61N/A-
Revenue84.8M0-
Total Cash431M409K105,379%
Total Debt16.4M13.9M118%
FUNDAMENTALS RATINGS
IMTX vs OTLC: Fundamental Ratings
IMTX
OTLC
OUTLOOK RATING
1..100
6950
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
9695
PRICE GROWTH RATING
1..100
3837
P/E GROWTH RATING
1..100
6394
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OTLC's Valuation (50) in the null industry is in the same range as IMTX (74). This means that OTLC’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's Profit vs Risk Rating (98) in the null industry is in the same range as OTLC (100). This means that IMTX’s stock grew similarly to OTLC’s over the last 12 months.

OTLC's SMR Rating (95) in the null industry is in the same range as IMTX (96). This means that OTLC’s stock grew similarly to IMTX’s over the last 12 months.

OTLC's Price Growth Rating (37) in the null industry is in the same range as IMTX (38). This means that OTLC’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's P/E Growth Rating (63) in the null industry is in the same range as OTLC (94). This means that IMTX’s stock grew similarly to OTLC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMTXOTLC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
81%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
77%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IMTX
Daily Signal:
Gain/Loss:
OTLC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KDHSX48.570.24
+0.50%
DWS CROCI Equity Dividend S
FCGPX20.620.05
+0.24%
NYLI PineStone Global Equity Class P
FWDDX13.880.03
+0.22%
American Funds Dvlpg Wld Gr&Inc 529-F-2
MAIRX9.930.01
+0.10%
Victory Trivalent Intl Fd-Core Eq R6
HSWRX21.94-0.02
-0.09%
Hartford Schroders International Stk R3

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IDYA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+1.47%
IDYA - IMTX
54%
Loosely correlated
+0.76%
CGON - IMTX
51%
Loosely correlated
+0.22%
VYGR - IMTX
50%
Loosely correlated
+2.01%
SYRE - IMTX
49%
Loosely correlated
-0.54%
CRNX - IMTX
48%
Loosely correlated
-0.33%
More

OTLC and

Correlation & Price change

A.I.dvisor tells us that OTLC and TENX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OTLC and TENX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLC
1D Price
Change %
OTLC100%
+1.12%
TENX - OTLC
23%
Poorly correlated
+4.93%
MNKD - OTLC
22%
Poorly correlated
N/A
IMTX - OTLC
21%
Poorly correlated
+1.47%
MMIRF - OTLC
15%
Poorly correlated
N/A
IPHYF - OTLC
4%
Poorly correlated
N/A
More